COMPANY
Hemanext
Timeline
- Trial start Not phased (device or behavioral study): Hypoxic Red Blood Cells in Sickle Cell Anemia source ↗
- Trial start Not phased (device or behavioral study): Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion source ↗
- Trial start —: Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital source ↗
- Trial start Phase 2: Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells source ↗
- Trial start Phase 2: Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial source ↗
Upcoming milestones
- 2028-05 (ESTIMATED) · Not phased · Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion · NCT06685848
- Apr 1, 2029 (ESTIMATED) · Not phased · Hypoxic Red Blood Cells in Sickle Cell Anemia · NCT06743113
Clinical trials (lead sponsor) 5
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06743113 | Hypoxic Red Blood Cells in Sickle Cell Anemia | Not phased (device or behavioral study) | Not yet recruiting | Sep 1, 2026 | Apr 1, 2029 (estimated) |
| NCT06685848 | Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion | Not phased (device or behavioral study) | Active, not recruiting | Nov 29, 2024 | 2028-05 (estimated) |
| NCT05549232 | Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital | Not listed | Completed | Aug 24, 2022 | May 16, 2024 (actual) |
| NCT04418934 | Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells | Phase 2 | Withdrawn | Jul 1, 2020 | May 1, 2021 (estimated) |
| NCT03301779 | Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial | Phase 2 | Completed | Nov 27, 2017 | Mar 6, 2019 (actual) |